Physician profile
Stephanie Carmichael
NPI 1649266552
$780.65
in general payments reported to CMS, 2019-2025
16 companies · $42.22 in 2025
The $42.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.78 · 2020: $98.29 · 2021: $335 · 2022: $98.21 · 2023: $59.83 · 2024: $100 · 2025: $42.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.97 | 2020-2021 | |
| Astellas Pharma US INC | $105.68 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $58.09 | 2021-2024 | |
| Evofem Biosciences, INC. | $57.11 | 2021 | |
| Lupin INC. | $47.89 | 2019-2021 | |
| Myovant Sciences INC. | $47.38 | 2021-2022 | |
| Aspira Women'S Health INC | $47.00 | 2021 | |
| Scynexis, INC. | $39.08 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.92 | 2023-2025 | Gardasil 9 |
| Hologic Sales and Service, LLC | $37.85 | 2019-2021 | |
| Allergan, INC. | $28.97 | 2019-2020 | |
| Agile Therapeutics, INC. | $24.28 | 2022 | |
| Millicent US INC | $23.17 | 2025 | Femlyv |
| Therapeuticsmd, INC. | $21.24 | 2022 | |
| Phadia US INC. | $17.82 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.